ID: ALA3330913

Max Phase: Preclinical

Molecular Formula: C37H41N5O2

Molecular Weight: 587.77

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cc(NC(C)CCCNC(=O)NCCNC(c2ccccc2)(c2ccccc2)c2ccccc2)c2ncccc2c1

Standard InChI:  InChI=1S/C37H41N5O2/c1-28(42-34-27-33(44-2)26-29-15-13-22-38-35(29)34)14-12-23-39-36(43)40-24-25-41-37(30-16-6-3-7-17-30,31-18-8-4-9-19-31)32-20-10-5-11-21-32/h3-11,13,15-22,26-28,41-42H,12,14,23-25H2,1-2H3,(H2,39,40,43)

Standard InChI Key:  PEUAJGPWAFZYPN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 587.77

Molecular Weight (Monoisotopic): 587.3260

AlogP: 6.70

#Rotatable Bonds: 14

Polar Surface Area: 87.31

Molecular Species: NEUTRAL

HBA: 5

HBD: 4

#RO5 Violations: 2

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 7.53

CX LogP: 6.14

CX LogD: 5.77

Aromatic Rings: 5

Heavy Atoms: 44

QED Weighted: 0.09

Np Likeness Score: -0.56

References

1. Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B..  (2014)  Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity.,  86  [PMID:25203780] [10.1016/j.ejmech.2014.09.013]

2. Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B..  (2018)  Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.,  146  [PMID:29407988] [10.1016/j.ejmech.2018.01.062]

Source

Source(1):

• Scientific Literature